2024 Binaytara Global Oncology Summit

Seattle, WA US
November 16, 2024

The Binaytara Foundation is excited to announce the Binaytara Global Oncology Summit, a one-day CME-accredited conference dedicated to addressing cancer care in low and middle-income countries (LMICs). This summit will bring together leading oncology experts, healthcare professionals, and researchers interested in global oncology to discuss innovative solutions and strategies to improve cancer care in resource-limited settings.

The Binaytara Global Oncology Summit aims to enhance the knowledge and skills of healthcare providers by offering comprehensive insights into the unique challenges and opportunities associated with cancer care in LMICs. The conference will cover a wide range of topics, including the latest advancements in cancer diagnosis and treatment, effective resource utilization, and the implementation of cost-effective care models.

Participants will benefit from in-depth discussions on integrating cutting-edge technologies, such as telemedicine and mobile health, to extend cancer care services in underserved areas. Additionally, the summit will showcase successful case studies and best practices in community-based cancer prevention, early detection, and palliative care.

Key themes of the conference will include the role of international collaboration, capacity building, and policy advocacy in strengthening oncology care systems in LMICs. Attendees will have the opportunity to engage in expert-led sessions, panel discussions, and interactive workshops designed to foster a collaborative and multidisciplinary approach to cancer care.

Target Audience

  • Physicians 
  • Nurse Practitioners/ Physician Assistants
  • Nurses
  • Pharmacists
  • Cancer Care Professionals
  • Others interested in Global Oncology

Organizing Committee

Conference Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair:

Jerry Radich, MD - Fred Hutchinson Cancer Center

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  1. Review the unique challenges and opportunities in delivering cancer care in low and middle-income countries (LMICs), and explore innovative solutions to overcome these barriers.
  2. Critically analyze the unique challenges and untapped opportunities in cancer care for low and middle-income countries (LMICs), focusing on overcoming socio-economic and healthcare barriers.
  3. Discuss cutting-edge advancements in cancer diagnosis and treatments, emphasizing resource-appropriate strategies that can be implemented effectively in resource-limited settings.
  4. Investigate the transformative impact of technologies in improving access to cancer care in LMICs, with a focus on telemedicine and mobile health solutions.
  5. Examine successful case studies from LMICs, and foster discussions on international collaboration, capacity building, and policy advocacy to create robust and sustainable oncology care systems.
  6. Review the critical role of engaging stakeholders and funders, explore innovative methods for building impactful partnerships, and explore career pathways in global oncology.

HOTEL INFORMATION

A limited number of rooms have been booked at the Hilton Motif Downtown Seattle at a discounted nightly rate of $189 per room for this conference's attendees and sponsors. Please book your room at the  link here  by October 15th, 2024 to receive the discounted group rate. The room rate doesn't include the discounted resort fee of $10 per room per night or any applicable taxes.

CUTOFF - Tuesday October 15, 2024

Parking

The hotel is offering a discounted self-parking of $55 local and overnight.

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 5.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.
Course opens: 
05/27/2024
Course expires: 
01/31/2025
Event starts: 
11/16/2024 - 8:00am PST
Event ends: 
11/16/2024 - 4:00pm PST
Cost:
$150.00

November 16th, 2024

All times are listed in Pacific Time (PT)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:15 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


08:15 AM – 09:15 AM  Session 1: Cancer Care in LMICs: Challenges and Opportunities

Session Chair: Corey Casper, MD, MPH

08:15 AM – 08:25 AM Keynote Lecture - Corey Casper, MD, MPH

08:25 AM – 09:15 AM  Panel Discussion - Sarah Kutika Nyagabona, MD, PhD; Shailender Bhatia, MD; Benjamin Li, MD, MBA; Geoff Cook; Katherine Van Loon, MD, MPH


09:15 AM – 10:15 AM  Session 2: Innovation in Diagnostics and Access 

Session Chair: Jerry Radich, MD

09:15 AM – 09:25 AM  Keynote Lecture - Jerry Radich, MD

09:25 AM – 10:15 AM  Panel Discussion - Cecilia CS Yeung, MD; Steven Kussick, MD, PhD; Naresh Kikeri, MBBS, DCP, MD, FRCPath


10:15 AM – 10:30 AM  Break & Exhibits


10:30 AM – 11:30 AM  Session 3: Technology

Session Chair: Nora Ku, MD

10:30 AM – 10:40 AM  Keynote Lecture: Advancing Health at the Speed of AI - Hoifung Poon, PhD

10:40 AM – 11:30 AM  Panel Discussion - Bradford Felker, MD; Michael Wrigglesworth; Joseph Rosales, MD


11:30 AM – 12:30 PM  Session 4: Abstracts

Session Chair: Jerald Radich, MD

11:30 AM - 11:45 AM  Survival Analysis of Carcinoma of Middle Third of Esophagus, a SEER Review - Sugam Gouli, MD

11:45 AM - 12:00 PM  hnRNPA1 promotes the metastasis and proliferation of gastric cancer cells through WISP2-guided Wnt/β-catenin signaling pathway - Chenyang Jiang, MD

12:00 PM - 12:15 PM  Phase 2 Trial of Low Dose, Reduced Frequency Nivolumab in Patients with Unresectable or Metastatic Cancer in Uganda: Trial-in-Progress - Gretė Ambrazevičiūtė, MD

12:15 PM - 12:30 PM  Dried Blood Spots for Monitoring in Chronic Myeloid Leukemia: Implications for Global Oncology - Vivian Oehler, MD


12:30 PM – 01:30 PM  Lunch & Exhibits


01:30 PM – 02:30 PM  Session 5: Healthcare Policy & Sustainable Care Models

Session Chair: Dan Milner, MD, MSc, FASCP

01:30 PM – 02:30 PM  Panel Discussion - Patrick Loehrer, MD; Surendra Prajapati, PhD; Catherine Duggan, PhD; James C. Dickerson, MD, MS


02:30 PM Key Takeaways & Adjourn

Hilton Motif Seattle
1415 5th Ave
Seattle, WA 98101
United States

Hotel Room Reservation

A limited number of rooms have been booked at the Hilton Motif Downtown Seattle at a discounted nightly rate of $189 per room for this conference's attendees and sponsors. Please book your room at the link here by October 15th, 2024 to receive the discounted group rate. The room rate doesn't include the discounted resort fee of $10 per room per night or any applicable taxes.

CUTOFF

Tuesday October 15, 2024

Parking

The hotel is offering a discounted self-parking of $55 local and overnight.

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Conference Chair(s)

Jerald Radich, MD

has a financial relationship (Other) with Novartis;.
has a financial relationship (Stock Options) with Biofidelity;.
has a financial relationship (Other) with HTG;.
Session Chair(s)

Corey Casper, MD, MPH

has a financial relationship (Grant Or Contract) with ImmunityBio;.
has a financial relationship (Stock Options) with Viracta Therapeutics;.
has a financial relationship (Independent contractor) with Recordati Rare Disease;.
has a financial relationship (Grant Or Contract) with Janssen Pharmaceutical;.

Nora Ku

has a financial relationship (Stock) with Eli Lilly;.
has a financial relationship (Employment) with Rain Oncology, Inc;.

Danny Milner, Jr, MD, MSc, MBA

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Shailender Bhatia, MD

has a financial relationship (Grant Or Contract) with Xencor;.
has a financial relationship (Grant Or Contract) with 4SC;.
has a financial relationship (Grant Or Contract) with Regeneron (fka Checkmate Pharmaceuticals);.
has a financial relationship (Grant Or Contract) with Kuni Foundation;.
has a financial relationship (Grant Or Contract) with Trisalus Life Sciences;.
has a financial relationship (Grant Or Contract) with Bristol Meyers Squibb;.
has a financial relationship (Grant Or Contract) with Incyte;.
has a financial relationship (Grant Or Contract) with Nektar Therapeutics;.
has a financial relationship (Professional Services) with Incyte;.
has a financial relationship (Grant Or Contract) with Amphivena;.
has a financial relationship (Grant Or Contract) with Exicure;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Grant Or Contract) with Agenus;.
has a financial relationship (Grant Or Contract) with EMD Serono;.

Geoff Cook

has a financial relationship (Independent contractor) with GlycoMimetics, Inc.;.
has a financial relationship (Independent contractor) with Pierre Fabre Pharmaceuticals, Inc.;.

James Dickerson, MD, MS

has no relevant financial relationships to disclose at this time.

Catherine Duggan

has no relevant financial relationships to disclose at this time.

Bradford Felker, MD

has no relevant financial relationships to disclose at this time.

Steven Kussick, MD, PhD

has no relevant financial relationships to disclose at this time.

Benjamin Li, MD, MBA

has no relevant financial relationships to disclose at this time.

Patrick Loehrer, M.D.

has no relevant financial relationships to disclose at this time.

Kikkeri Naresh

has no relevant financial relationships to disclose at this time.

Sarah Nyagabona, Clinical Oncologist MD, Mmed

has no relevant financial relationships to disclose at this time.

Hoifung Poon, PhD, University of Washington

has a financial relationship (Other) with Sanofi;.

Surendra Prajapati

has no relevant financial relationships to disclose at this time.

Joseph Rosales, MD

has no relevant financial relationships to disclose at this time.

Katherine Van Loon, MD, MPH

has no relevant financial relationships to disclose at this time.

Michael Wrigglesworth, VP, Programs Operations, The Max Foundation

has no relevant financial relationships to disclose at this time.

Cecilia Yeung, MD

has a financial relationship (Other) with Twinstrands;.

Available Credit

  • 5.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.